Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/126020
Title: | Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial |
Author: | Rubio Borrego, Francisco Ramón Krupinski, Y. Carvajal, Ana Arboix, A. (Adrià) SPS3 Investigators |
Keywords: | Pressió sanguínia Manifestacions neurològiques de les malalties Blood pressure Neurologic manifestations of general diseases |
Issue Date: | 10-Aug-2013 |
Publisher: | Elsevier B.V. |
Abstract: | Background: Lowering of blood pressure prevents stroke but optimum target levels to prevent recurrent stroke are unknown. We investigated the effects of different blood-pressure targets on the rate of recurrent stroke in patients with recent lacunar stroke. Methods: In this randomised open-label trial, eligible patients lived in North America, Latin America, and Spain and had recent, MRI-defined symptomatic lacunar infarctions. Patients were recruited between March, 2003, and April, 2011, and randomly assigned, according to a two-by-two multifactorial design, to a systolic-blood-pressure target of 130-149 mm Hg or less than 130 mm Hg. The primary endpoint was reduction in all stroke (including ischaemic strokes and intracranial haemorrhages). Analysis was done by intention to treat. This study is registered with ClinicalTrials.gov, number NCT 00059306. Findings: 3020 enrolled patients, 1519 in the higher-target group and 1501 in the lower-target group, were followed up for a mean of 3·7 (SD 2·0) years. Mean age was 63 (SD 11) years. After 1 year, mean systolic blood pressure was 138 mm Hg (95% CI 137-139) in the higher-target group and 127 mm Hg (95% CI 126-128) in the lower-target group. Non-significant rate reductions were seen for all stroke (hazard ratio 0·81, 95% CI 0·64-1·03, p=0·08), disabling or fatal stroke (0·81, 0·53-1·23, p=0·32), and the composite outcome of myocardial infarction or vascular death (0·84, 0·68-1·04, p=0·32) with the lower target. The rate of intracerebral haemorrhage was reduced significantly (0·37, 0·15-0·95, p=0·03). Treatment-related serious adverse events were infrequent. Interpretation: Although the reduction in stroke was not significant, our results support that in patients with recent lacunar stroke, the use of a systolic-blood-pressure target of less than 130 mm Hg is likely to be beneficial. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1016/S0140-6736(13)60852-1 |
It is part of: | The Lancet, 2013, vol. 382, num. 9891, p. 507-515 |
URI: | http://hdl.handle.net/2445/126020 |
Related resource: | https://doi.org/10.1016/S0140-6736(13)60852-1 |
ISSN: | 0140-6736 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
650452.pdf | 1.09 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.